Review



human retinal pigment epithelial cell line arpe 19 cells  (Procell Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Procell Inc human retinal pigment epithelial cell line arpe 19 cells
    Preparation and characterization of the conjugates (A) Schematic diagram of responsive release of the conjugates. (B) Particle size and distribution of aVEGFA, MPEG-aVEGFA, and the conjugates. (C) Particle size changes of aVEGFA, MPEG-aVEGFA, and the conjugates after incubation in hydrogen peroxide. (D) Transmission electron microscopy images of aVEGFA and the conjugates, scale bar = 100 nm. (E–G) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aVEGFA. (H, I) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aPDL1. (J, K) Cytotoxicity evaluation of TAT-MPEG-aVEGFA on HCE-T cells and ARPE19 cells. (L, M) Scratch assay results estimating angiogenesis inhibition, and quantitative analysis. n.s. (not significant) p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 versus control. Abbreviations: aVEGFA, anti–vascular endothelial growth factor A antibody; TAT-MPEG, trans-activator of transcription peptide–methoxy polyethylene glycol; <t>ARPE-19,</t> human retinal pigment epithelial cell line; HCE-T, human corneal epithelial cell line.
    Human Retinal Pigment Epithelial Cell Line Arpe 19 Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+retinal+pigment+epithelial+cell+line+arpe+19+cells/pmc12877828-144-11-30?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    human retinal pigment epithelial cell line arpe 19 cells - by Bioz Stars, 2026-07
    86/100 stars

    Images

    1) Product Images from "ROS-responsive transmembrane peptide-antibody conjugate eyedrops for the non-invasive treatment of choroidoretinopathy"

    Article Title: ROS-responsive transmembrane peptide-antibody conjugate eyedrops for the non-invasive treatment of choroidoretinopathy

    Journal: Materials Today Bio

    doi: 10.1016/j.mtbio.2026.102819

    Preparation and characterization of the conjugates (A) Schematic diagram of responsive release of the conjugates. (B) Particle size and distribution of aVEGFA, MPEG-aVEGFA, and the conjugates. (C) Particle size changes of aVEGFA, MPEG-aVEGFA, and the conjugates after incubation in hydrogen peroxide. (D) Transmission electron microscopy images of aVEGFA and the conjugates, scale bar = 100 nm. (E–G) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aVEGFA. (H, I) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aPDL1. (J, K) Cytotoxicity evaluation of TAT-MPEG-aVEGFA on HCE-T cells and ARPE19 cells. (L, M) Scratch assay results estimating angiogenesis inhibition, and quantitative analysis. n.s. (not significant) p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 versus control. Abbreviations: aVEGFA, anti–vascular endothelial growth factor A antibody; TAT-MPEG, trans-activator of transcription peptide–methoxy polyethylene glycol; ARPE-19, human retinal pigment epithelial cell line; HCE-T, human corneal epithelial cell line.
    Figure Legend Snippet: Preparation and characterization of the conjugates (A) Schematic diagram of responsive release of the conjugates. (B) Particle size and distribution of aVEGFA, MPEG-aVEGFA, and the conjugates. (C) Particle size changes of aVEGFA, MPEG-aVEGFA, and the conjugates after incubation in hydrogen peroxide. (D) Transmission electron microscopy images of aVEGFA and the conjugates, scale bar = 100 nm. (E–G) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aVEGFA. (H, I) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aPDL1. (J, K) Cytotoxicity evaluation of TAT-MPEG-aVEGFA on HCE-T cells and ARPE19 cells. (L, M) Scratch assay results estimating angiogenesis inhibition, and quantitative analysis. n.s. (not significant) p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 versus control. Abbreviations: aVEGFA, anti–vascular endothelial growth factor A antibody; TAT-MPEG, trans-activator of transcription peptide–methoxy polyethylene glycol; ARPE-19, human retinal pigment epithelial cell line; HCE-T, human corneal epithelial cell line.

    Techniques Used: Incubation, Transmission Assay, Electron Microscopy, In Vitro, Wound Healing Assay, Inhibition, Control



    Similar Products

    human retinal pigment epithelial cell line arpe 19  (ATCC)
    99
    ATCC human retinal pigment epithelial cell line arpe 19
    Human Retinal Pigment Epithelial Cell Line Arpe 19, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+retinal+pigment+epithelial+cell+line+arpe+19+cells/pm41866544-32-31-39?v=ATCC
    Average 99 stars, based on 1 article reviews
    human retinal pigment epithelial cell line arpe 19 - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier
    human retinal pigment epithelial cell line arpe 19 cells  (Procell Inc)
    86
    Procell Inc human retinal pigment epithelial cell line arpe 19 cells
    Preparation and characterization of the conjugates (A) Schematic diagram of responsive release of the conjugates. (B) Particle size and distribution of aVEGFA, MPEG-aVEGFA, and the conjugates. (C) Particle size changes of aVEGFA, MPEG-aVEGFA, and the conjugates after incubation in hydrogen peroxide. (D) Transmission electron microscopy images of aVEGFA and the conjugates, scale bar = 100 nm. (E–G) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aVEGFA. (H, I) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aPDL1. (J, K) Cytotoxicity evaluation of TAT-MPEG-aVEGFA on HCE-T cells and ARPE19 cells. (L, M) Scratch assay results estimating angiogenesis inhibition, and quantitative analysis. n.s. (not significant) p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 versus control. Abbreviations: aVEGFA, anti–vascular endothelial growth factor A antibody; TAT-MPEG, trans-activator of transcription peptide–methoxy polyethylene glycol; <t>ARPE-19,</t> human retinal pigment epithelial cell line; HCE-T, human corneal epithelial cell line.
    Human Retinal Pigment Epithelial Cell Line Arpe 19 Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+retinal+pigment+epithelial+cell+line+arpe+19+cells/pmc12877828-144-11-30?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    human retinal pigment epithelial cell line arpe 19 cells - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    te human retinal pigment epithelial cell line  (ATCC)
    99
    ATCC te human retinal pigment epithelial cell line
    Preparation and characterization of the conjugates (A) Schematic diagram of responsive release of the conjugates. (B) Particle size and distribution of aVEGFA, MPEG-aVEGFA, and the conjugates. (C) Particle size changes of aVEGFA, MPEG-aVEGFA, and the conjugates after incubation in hydrogen peroxide. (D) Transmission electron microscopy images of aVEGFA and the conjugates, scale bar = 100 nm. (E–G) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aVEGFA. (H, I) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aPDL1. (J, K) Cytotoxicity evaluation of TAT-MPEG-aVEGFA on HCE-T cells and ARPE19 cells. (L, M) Scratch assay results estimating angiogenesis inhibition, and quantitative analysis. n.s. (not significant) p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 versus control. Abbreviations: aVEGFA, anti–vascular endothelial growth factor A antibody; TAT-MPEG, trans-activator of transcription peptide–methoxy polyethylene glycol; <t>ARPE-19,</t> human retinal pigment epithelial cell line; HCE-T, human corneal epithelial cell line.
    Te Human Retinal Pigment Epithelial Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+retinal+pigment+epithelial+cell+line+arpe+19+cells/pm41497724-41-0-12?v=ATCC
    Average 99 stars, based on 1 article reviews
    te human retinal pigment epithelial cell line - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier
    human retinal pigment epithelial cell line  (ATCC)
    99
    ATCC human retinal pigment epithelial cell line
    Preparation and characterization of the conjugates (A) Schematic diagram of responsive release of the conjugates. (B) Particle size and distribution of aVEGFA, MPEG-aVEGFA, and the conjugates. (C) Particle size changes of aVEGFA, MPEG-aVEGFA, and the conjugates after incubation in hydrogen peroxide. (D) Transmission electron microscopy images of aVEGFA and the conjugates, scale bar = 100 nm. (E–G) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aVEGFA. (H, I) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aPDL1. (J, K) Cytotoxicity evaluation of TAT-MPEG-aVEGFA on HCE-T cells and ARPE19 cells. (L, M) Scratch assay results estimating angiogenesis inhibition, and quantitative analysis. n.s. (not significant) p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 versus control. Abbreviations: aVEGFA, anti–vascular endothelial growth factor A antibody; TAT-MPEG, trans-activator of transcription peptide–methoxy polyethylene glycol; <t>ARPE-19,</t> human retinal pigment epithelial cell line; HCE-T, human corneal epithelial cell line.
    Human Retinal Pigment Epithelial Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+retinal+pigment+epithelial+cell+line+arpe+19+cells/us12357564-568-0-16?v=ATCC
    Average 99 stars, based on 1 article reviews
    human retinal pigment epithelial cell line - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier
    human retinal pigment epithelial cell line arpe  (ATCC)
    99
    ATCC human retinal pigment epithelial cell line arpe
    Preparation and characterization of the conjugates (A) Schematic diagram of responsive release of the conjugates. (B) Particle size and distribution of aVEGFA, MPEG-aVEGFA, and the conjugates. (C) Particle size changes of aVEGFA, MPEG-aVEGFA, and the conjugates after incubation in hydrogen peroxide. (D) Transmission electron microscopy images of aVEGFA and the conjugates, scale bar = 100 nm. (E–G) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aVEGFA. (H, I) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aPDL1. (J, K) Cytotoxicity evaluation of TAT-MPEG-aVEGFA on HCE-T cells and ARPE19 cells. (L, M) Scratch assay results estimating angiogenesis inhibition, and quantitative analysis. n.s. (not significant) p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 versus control. Abbreviations: aVEGFA, anti–vascular endothelial growth factor A antibody; TAT-MPEG, trans-activator of transcription peptide–methoxy polyethylene glycol; <t>ARPE-19,</t> human retinal pigment epithelial cell line; HCE-T, human corneal epithelial cell line.
    Human Retinal Pigment Epithelial Cell Line Arpe, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+retinal+pigment+epithelial+cell+line+arpe+19+cells/pm40015005-229-38-48?v=ATCC
    Average 99 stars, based on 1 article reviews
    human retinal pigment epithelial cell line arpe - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Preparation and characterization of the conjugates (A) Schematic diagram of responsive release of the conjugates. (B) Particle size and distribution of aVEGFA, MPEG-aVEGFA, and the conjugates. (C) Particle size changes of aVEGFA, MPEG-aVEGFA, and the conjugates after incubation in hydrogen peroxide. (D) Transmission electron microscopy images of aVEGFA and the conjugates, scale bar = 100 nm. (E–G) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aVEGFA. (H, I) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aPDL1. (J, K) Cytotoxicity evaluation of TAT-MPEG-aVEGFA on HCE-T cells and ARPE19 cells. (L, M) Scratch assay results estimating angiogenesis inhibition, and quantitative analysis. n.s. (not significant) p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 versus control. Abbreviations: aVEGFA, anti–vascular endothelial growth factor A antibody; TAT-MPEG, trans-activator of transcription peptide–methoxy polyethylene glycol; ARPE-19, human retinal pigment epithelial cell line; HCE-T, human corneal epithelial cell line.

    Journal: Materials Today Bio

    Article Title: ROS-responsive transmembrane peptide-antibody conjugate eyedrops for the non-invasive treatment of choroidoretinopathy

    doi: 10.1016/j.mtbio.2026.102819

    Figure Lengend Snippet: Preparation and characterization of the conjugates (A) Schematic diagram of responsive release of the conjugates. (B) Particle size and distribution of aVEGFA, MPEG-aVEGFA, and the conjugates. (C) Particle size changes of aVEGFA, MPEG-aVEGFA, and the conjugates after incubation in hydrogen peroxide. (D) Transmission electron microscopy images of aVEGFA and the conjugates, scale bar = 100 nm. (E–G) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aVEGFA. (H, I) Schematic diagram and quantitative results of in vitro experiments assessing corneal penetration ability of FITC-aPDL1. (J, K) Cytotoxicity evaluation of TAT-MPEG-aVEGFA on HCE-T cells and ARPE19 cells. (L, M) Scratch assay results estimating angiogenesis inhibition, and quantitative analysis. n.s. (not significant) p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 versus control. Abbreviations: aVEGFA, anti–vascular endothelial growth factor A antibody; TAT-MPEG, trans-activator of transcription peptide–methoxy polyethylene glycol; ARPE-19, human retinal pigment epithelial cell line; HCE-T, human corneal epithelial cell line.

    Article Snippet: Murine melanoma (B16) cells were obtained from COBIOER Biotechnology (Nanjing, China), human retinal pigment epithelial cell line (ARPE-19) cells and human corneal epithelial cell line (HCE-T) cells were obtained from ProCell Biotechnology (Wuhan, China), HUVECs were obtained from SUNNCELL Biotechnology (Wuhan, China).

    Techniques: Incubation, Transmission Assay, Electron Microscopy, In Vitro, Wound Healing Assay, Inhibition, Control